🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

10 results for “ATOSSA” Clear

  1. ForeCYTE Breast Aspirator

    ATOSSA THERAPEUTICS, INC.

    Breast Cancer, Preneoplastic Conditions, BRCA

    phase 3 other terminated

    1 trial

  2. (Z)-endoxifen

    ATOSSA THERAPEUTICS, INC.

    Breast Neoplasms

    phase 2 small molecule active

    1 trial

  3. ASCAPE-based follow-up strategy

    ATOSSA THERAPEUTICS, INC.

    Breast Cancer

    phase 2 other active

    1 trial

  4. Fulvestrant

    ATOSSA THERAPEUTICS, INC.

    Female Breast Carcinoma

    phase 2 small molecule terminated

    1 trial

  5. Provox Vega voice prosthesis 22.5 Fr

    ATOSSA THERAPEUTICS, INC.

    Total Laryngectomy

    phase 2 other completed

    1 trial

  6. Provox voice prosthesis

    ATOSSA THERAPEUTICS, INC.

    Total Laryngectomy

    phase 2 other completed

    1 trial

  7. Topical endoxifen

    ATOSSA THERAPEUTICS, INC.

    Mammographic Breast Density

    phase 2 small molecule completed

    1 trial

  8. Z-Endoxifen

    ATOSSA THERAPEUTICS, INC.

    Breast Density

    phase 2 small molecule completed

    1 trial

  9. AT-301B

    ATOSSA THERAPEUTICS, INC.

    Healthy

    phase 1 small molecule completed

    1 trial

  10. Provox Xtra HME

    ATOSSA THERAPEUTICS, INC.

    Total Laryngectomy

    phase 1 other completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources